LYNCH DANIEL - Insider Non-Derivative Transactions at SpringWorks Therapeutics, Inc. (SWTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jul 1, 2025, LYNCH DANIEL's relationship to SpringWorks Therapeutics, Inc. (SWTX) is Director, and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SWTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

LYNCH DANIEL - Insider Non-Derivative Transactions of SWTX Common Stock

LYNCH DANIEL - Insider Non-Derivative Transactions at SWTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jul 2, 2025	Disposition -- (Common Stock)	93004	0	0
May 15, 2025	Acquisition -- (Common Stock)	10060	0	93004
Feb 21, 2025	Sell -- (Common Stock)	3582	61.24	82944
Feb 21, 2025	Sell -- (Common Stock)	44018	60.14	86526
Feb 15, 2025	Sell -- (Common Stock)	400	60	130544
Feb 11, 2025	Sell -- (Common Stock)	65600	55.51	130944
Feb 11, 2025	Sell -- (Common Stock)	39634	54.88	196544
Feb 11, 2025	Sell -- (Common Stock)	69766	53.23	236178
May 17, 2024	Acquisition -- (Common Stock)	4095	0	305944
May 25, 2023	Acquisition -- (Common Stock)	4648	0	301849